Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 08/30 10:01:26 pm
7.45 USD   +0.40%
08/29 RITE AID : to Offer Naloxone Without Prescription in 13 States
08/29DJWalgreens Forms Alliance With Prime Therapeutics
08/26 RITE AID : Foundation Donates Additional $50,000 to American Red Cro..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
08/29 RITE AID : Blumenthal applauds rite aid decision to offer naloxone without presc..
08/29 RITE AID : to Offer Naloxone Without Prescription in 13 States
08/29DJWalgreens Forms Alliance With Prime Therapeutics
08/26 RITE AID : Foundation Donates Additional $50,000 to American Red Cross to Assist..
08/26 ON BIZWIRETV : Big Name Brands Join Louisiana Relief Effort and a Social Experim..
08/25 RITE AID : Flu Shots Now Available at Rite Aid
08/24 RITE AID : Eastpointe man shot by 91-year-old Detroiter is charged
08/24 ROBBERS TAKE PAINKILLERS FROM LEBANO : Police
08/24 HONDA MOTOR : Man Hit By Car On Morgan Street In Stamford
08/24 RITE AID : to open Thursday in downtown Allentown
More news
Sector news : Retail - Drugs without Grocery
02:55aDJWALGREENS BOOTS ALLIANCE : Theranos Walks Away From Zika Test
08/30DJFirms Drop Prettied-Up Results -- WSJ
08/29DJWALGREENS BOOTS ALLIANCE : Forms Alliance With Prime Therapeutics -- Update
08/29DJCompanies Play Up Standard Accounting Figures
08/29DJWALGREENS BOOTS ALLIANCE : Forms Alliance With Prime Therapeutics
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
08/29 Trump Is Still Winning
08/22 Berkshire Boosts Apple Stake And Other Moves From Top Managers
08/19 Top Merger Stocks Held By Fund Managers (Mid-Q3 2016 Edition)
08/18 Activists Circling Bank Of America?
08/18 RITE AID : Hedge Funds Circle To Take Advantage Of The Arbitrage
Advertisement
Financials ($)
Sales 2017 32 966 M
EBIT 2017 709 M
Net income 2017 151 M
Debt 2017 6 717 M
Yield 2017 -
P/E ratio 2017 46,03
P/E ratio 2018 29,76
EV / Sales 2017 0,44x
EV / Sales 2018 0,41x
Capitalization 7 783 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 8,86 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-5.36%7 783
RAIA DROGASIL SA69.03%6 104
AIN HOLDINGS INC2.09%1 825
ORIOLA KD OYJ-2.31%882
AUSTRALIAN PHARMACEUTI..-1.04%685
ADCOCK INGRAM HOLDINGS..-5.51%565
More Results